Institutional investors own a significant stake of 42% in Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS)

Key Insights Significantly high institutional ownership implies Acumen Pharmaceuticals' stock price is sensitive to...

Related Keywords

Robert Hardie ,Acumen Pharmaceuticals Inc ,Sands Capital Ventures ,Acumen Pharmaceuticals ,Institutional Ownership Tell Us About Acumen Pharmaceuticals ,Acumen Pharmaceutical ,Institutional Ownership ,Nstitutions ,Nsider Ownership ,Institutional Investors ,